India has become the country with the highest number of diabetics, with over 212 million people affected in 2022. The latest ...

While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

2 Top Growth Stocks to Buy on the Dip was originally published by The Motley Fool ...

Study conducted by NCD Risk Factor Collaboration (NCD-RisC) and WHO. Findings part of first global analysis of trends in both ...

Band Aid's 1984 single never fails to dominate the UK radio waves every December - serving as a reminder of the tragedies ...

A signed banner that reads 'SickKids loves Taylor' stretches between two trees on the front lawn of Toronto's Hospital for ...

The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million—over four ...

A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication that the market for GLP-1 drugs could likely be a lot bigger. Based on data ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

On 14 November 2024, the U.S. Centers for Medicare & Medicaid Services (CMS) issued a final Local Coverage Determination (LCD) 1 policy regarding skin substitute grafts/cellular and tissue-based ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Specifically, the company reported positive updates on its Duodenal Mucosal Resurfacing (DMR) used in the treatment of ...